MDS Science Advancing Health 2008 Annual Report
Company Profile 2008 Financial Highlights Our Businesses Message to Shareholders Key Focus Areas PDF Index
Email this page Default font size Increase font size Increase font size

COMPANY PROFILE

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs, and the diagnosis and treatment of disease. The Company is a leading global provider of analytical instruments, medical isotopes for molecular imaging, radiotherapeutics, and pharmaceutical contract research.

Quick Facts    
  • $1.2 billion net revenues
  • 9% net revenues growth
  • 4% adjusted EBITDA growth
  • More than 5,000 employees
  • Broad global reach
    • Operations in 29 countries
    • Distribution to 64 countries
  • Listed on TSX and NYSE
  • 72% of institutional shares held
    outside Canada
Statistics
Employees by geography   Net Revenues by geography
Net Revenue by client type Net Revenues by offering

All dollar figures in this report are in U.S. funds unless otherwise stated.

 

Our Businesses - MDS Analytical Technologies
Our Businesses - MDS Nordion
Our Businesses - MDS Pharma Services
Key Focus Areas - Innovation
Key Focus Areas - Operational Excellence
Key Focus Areas - Globalization